2026 AMR Benchmark

AMR doesn’t just threaten infection control. It undermines modern medicine.

Learn why AMR matters

News

Read the latest at the Foundation

Foundation's new report reveals opportunities for generic medicine manufacturers to bridge access gaps in Africa

2026 Index Methodology zeroes in on scalable actions capable of delivering lasting impact for more people

Research hub

Explore our research reports and publications

High-level roundtable on how patient reach data can be leveraged for emerging market opportunities – Meeting Report

29 October 2026

Access to diabetes care for children and young people: Pharma companies' current actions and opportunities ahead

Patient centricity: How is the pharma industry addressing patient reach?

10 September 2024

Events and engagements

Sharing our insights to help drive change

Panel discussion

Margo Warren to attend second annual AI in Health Summit

04 November 2026

Steffi Van Uytfanghe to present insights on medical oxygen access gaps at 2026 Gasworld’s Global Industrial Gas Conference

02 December 2026

Foundation to host live webinar on key findings of the 2026 Access to Medicine Index

26 January 2027

Featured Launch

UBS and Neuberger Berman to co-host investor launch events for the tenth Access to Medicine Index

10 November 2026

Access insights

Read our analyses of critical developments in the pharmaceutical industry

Gilead to extend access to lenacapavir and broaden its voluntary licences to include a new once-yearly formulation

21 September 2026

Turning momentum into vaccine manufacturing capacity in Africa